Meso Scale Diagnostics, founded in 1995, develops, manufactures, and commercializes assays and instruments for measuring molecules in biological samples. The company operates globally, serving pharmaceutical and medical research, drug development, clinical laboratories, government institutions, and universities.
Its core technology, MULTI-ARRAY, enables researchers to profile multiple biomarkers simultaneously in a single sample without compromising assay performance. The company's electrochemiluminescence-based detection system provides high sensitivity and multiplex functionality for biological assays.
Meso Scale Diagnostics works across several technical domains, including bioassays, immunoassays, electrochemiluminescence, and multiplex biomarker detection. These capabilities support a range of applications from basic research to clinical diagnostics.
